Patricia A. Martin An2 Therapeutics, Inc. (ANTX) insider trading activity

Patricia A. Martin is of AN2 Therapeutics, Inc.. Currently has a direct ownership of 13,255 shares of ANTX, which is worth approximately $15,110. The most recent transaction as insider was on Oct 10, 2025, when has been sold 3,274 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.3K

32.8% 3M change

318.67% 12M change

Total Value Held $15,110

Patricia A. Martin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 10 2025	BUY Grant, award, or other acquisition	-	3,274 Added 19.81%	13,255 Common Stock
Jul 10 2025	BUY Grant, award, or other acquisition	-	3,750 Added 27.31%	9,981 Common Stock
Apr 10 2025	BUY Grant, award, or other acquisition	-	3,065 Added 32.97%	6,231 Common Stock
Dec 19 2024	BUY Grant, award, or other acquisition	-	3,166 Added 50.0%	3,166 Common Stock

Also insider at

LPTX

LEAP THERAPEUTICS, INC. Healthcare

Director

PAM